Garmin Lily 2 review: At a glance. What is it? The Garmin Lily 2 is the company's follow-up to its 2021 female-focused fitness tracker.The updated device still offers reliable wellness tracking on ...

Eli Lilly, one of the biggest makers of insulin, has been planning a risky new business venture: making the high-tech devices that deliver insulin to diabetes patients.

Eli Lilly and Dexcom announced a global commercialization agreement to integrate DexCom’s continuous glucose monitoring devices into a personalized diabetes management system currently in ...

Insulin maker Eli Lilly has signed an agreement with Switzerland-based Ypsomed to develop a closed loop system for people with diabetes, but it would only work with Lilly insulins in the U.S.

Shares of medical-device makers ResMed Inc. and Inspire Medical Systems Inc. tumbled on Monday after Eli Lilly & Co. said it has applied for regulatory approval of its weight-loss drug Zepbound to ...

Eli Lilly will open a new drug delivery and device innovation center in Cambridge, MA. Medical devices aren't a focus for the pharma now--but it noted that more than half of its current pipeline ...

Roche Holding AG RHHBY announced a collaboration with Eli Lilly and Company LLY where the latter shall support the development of Roche’s Elecsys Amyloid Plasma Panel (EAPP). EAPP is Roche’s ...

The pump, which Ypsomed initially planned to submit for FDA clearance in 2022 and which Lilly would’ve been responsible for selling throughout the U.S., would run on cartridges pre-filled with ...

Apple and pharmaceutical giant Eli Lilly are conducting joint research to see whether health features on the iPhone and Apple Watch can detect evidence of dementia and cognitive decline. The two ...

Eli Lilly yet to win U.K. nod for weight loss drug delivery device Nov. 09, 2023 10:51 AM ET Eli Lilly and Company (LLY) Stock NVO , NONOF By: Dulan Lokuwithana , SA News Editor JHVEPhoto ...

Roche and Eli Lilly's Elecsys pTau217 assay received FDA Breakthrough Device Designation for early diagnosis of Alzheimer's disease. Skip to content Home page Seeking Alpha - Power to Investors ...